跳至主要内容
临床试验/EUCTR2008-005925-12-DE
EUCTR2008-005925-12-DE进行中(未招募)1 期

Polyomavirus BK nephropathy after renal transplantation: Randomized clinical trial to demonstrate that switching to mTOR inhibitor is more effective than a reduction of immunosuppressive therapy - POLYOMA STUDY

Medizinische Hochschule Hannover0 个研究点目标入组 120 人开始时间: 2010年12月29日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Preceding transplantation;
  • functioning graft with a permanent glomerular filtration rate of >30mL/min; bioptically confirmed polyomavirus BK nephropathy;
  • age of 19 - 75 years;
  • written consent of the patient.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • known intolerance of the planned medication (e.g. severe diarrhea, angioedema, severe wound healing problem, uncontrolled infectious diseases other than BK virus);
  • leucopenia <2000/µL;
  • permanent glomerular filtration rate of <30mL/min.

研究者

发起方
Medizinische Hochschule Hannover

相似试验